查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1316752

CRISPR 和 Cas 基因市場：按組件（產品、服務）、用途（農業、生物醫學）、最終用戶 - 2023-2030 年全球預測

CRISPR & Cas Genes Market by Component (Product, Service), Application (Agricultural, Biomedical), End-user - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計 2023 年 CRISPR 和 Cas 基因的全球市場將達到 3813.43 百萬美元，年複合成長率為 32.38%，預計到 2030 年將出現驚人的成長，達到 2721127 萬美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球CRISPR&Cas基因市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.CRISPR&Cas基因的全球市場規模及預測為何？

2. 在預測期內，COVID-19 對全球 CRISPR 和 Cas Gene 市場的阻礙因素和影響有哪些？

3.在預測期內，全球CRISPR和Cas基因市場需要投資哪些產品/細分市場/應用/領域？

4.全球CRISPR&Cas基因市場的競爭策略為何？

5.全球CRISPR&Cas基因市場的技術趨勢與法律規範是什麼？

6.全球CRISPR&Cas基因市場主要廠商的市佔率是多少？

7.型態和策略措施被認為適合CRISPR&Cas基因進入全球市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 開發基於 CRISPR 的樣本組織篩選診斷方法
      • 遺傳疾病罹患率率高
      • 增加在藥物研發、醫學研究和非基因改造出血的應用
    • 抑制因素
      • CRISPR技術的脫靶效應
    • 機會
      • 抗CRISPR蛋白的進化
      • CRISPR-Cas基因新應用的研發
    • 任務
      • 專利形勢與糾紛
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 CRISPR 和 Cas 基因市場：按組成部分

  • 產品
    • 抗體
    • 設計工具
    • 試劑盒和酶
      • 無 DNA 鈣
      • 基於向量的Cas
    • 圖書館
  • 服務
    • 細胞株工程
    • DNA合成
    • gRNA設計
    • 微生物基因編輯

第7章 CRISPR 和 Cas 基因市場：按用途

  • 農業
  • 生物醫學醫學
    • 疾病模型研究
    • 表觀遺傳學
    • 功能基因體學
    • 基因組工程

第8章 CRISPR 和 Cas 基因市場：按最終用戶分類

  • 學術和政府研究機構
  • 生物技術和製藥公司
  • 合約研究組織

第9章 美洲CRISPR和Cas基因市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太CRISPR和Cas基因市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的CRISPR和Cas基因市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-5642D503D850

The Global CRISPR & Cas Genes Market is forecasted to grow significantly, with a projected USD 3,813.43 million in 2023 at a CAGR of 32.38% and expected to reach a staggering USD 27,211.27 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global CRISPR & Cas Genes Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global CRISPR & Cas Genes Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Component, market is studied across Product and Service. The Product is further studied across Antibodies, Design Tool, Kits & Enzymes, and Libraries. The Kits & Enzymes is further studied across DNA-Free Cas and Vector-Based Cas. The Service is further studied across Cell Line Engineering, DNA Synthesis, gRNA Design, and Microbial Gene Editing. The Product is projected to witness significant market share during forecast period.

Based on Application, market is studied across Agricultural and Biomedical. The Biomedical is further studied across Disease Model Studies, Epigenetics, Functional Genomics, and Genome Engineering. The Biomedical is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Academics & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations. The Biotechnology & Pharmaceutical Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global CRISPR & Cas Genes Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global CRISPR & Cas Genes Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global CRISPR & Cas Genes Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global CRISPR & Cas Genes Market?

4. What is the competitive strategic window for opportunities in the Global CRISPR & Cas Genes Market?

5. What are the technology trends and regulatory frameworks in the Global CRISPR & Cas Genes Market?

6. What is the market share of the leading vendors in the Global CRISPR & Cas Genes Market?

7. What modes and strategic moves are considered suitable for entering the Global CRISPR & Cas Genes Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. CRISPR & Cas Genes Market, by Component, 2022 vs 2030
  • 4.3. CRISPR & Cas Genes Market, by Application, 2022 vs 2030
  • 4.4. CRISPR & Cas Genes Market, by End-user, 2022 vs 2030
  • 4.5. CRISPR & Cas Genes Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Development of CRISPR-based diagnostic assays for sample tissue screening
      • 5.1.1.2. High prevalence of genetic disorders
      • 5.1.1.3. Rising application in drug discovery, biomedical research, and non-transgenic bleeding
    • 5.1.2. Restraints
      • 5.1.2.1. Off-target effects of CRISPR technology
    • 5.1.3. Opportunities
      • 5.1.3.1. Evolution of anti-CRISPR protein
      • 5.1.3.2. Research and development for novel application of CRISPR-Cas genes
    • 5.1.4. Challenges
      • 5.1.4.1. Patent landscape and dispute
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. CRISPR & Cas Genes Market, by Component

  • 6.1. Introduction
  • 6.2. Product
    • 6.2.1. Antibodies
    • 6.2.2. Design Tool
    • 6.2.3. Kits & Enzymes
      • 6.2.3.1. DNA-Free Cas
      • 6.2.3.2. Vector-Based Cas
    • 6.2.4. Libraries
  • 6.3. Service
    • 6.3.1. Cell Line Engineering
    • 6.3.2. DNA Synthesis
    • 6.3.3. gRNA Design
    • 6.3.4. Microbial Gene Editing

7. CRISPR & Cas Genes Market, by Application

  • 7.1. Introduction
  • 7.2. Agricultural
  • 7.3. Biomedical
    • 7.3.1. Disease Model Studies
    • 7.3.2. Epigenetics
    • 7.3.3. Functional Genomics
    • 7.3.4. Genome Engineering

8. CRISPR & Cas Genes Market, by End-user

  • 8.1. Introduction
  • 8.2. Academics & Government Research Institutes
  • 8.3. Biotechnology & Pharmaceutical Companies
  • 8.4. Contract Research Organizations

9. Americas CRISPR & Cas Genes Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific CRISPR & Cas Genes Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa CRISPR & Cas Genes Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CRISPR & CAS GENES MARKET RESEARCH PROCESS
  • FIGURE 2. CRISPR & CAS GENES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
  • FIGURE 5. CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. CRISPR & CAS GENES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. CRISPR & CAS GENES MARKET DYNAMICS
  • FIGURE 9. CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. CRISPR & CAS GENES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. CRISPR & CAS GENES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CRISPR & CAS GENES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 5. CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CRISPR & CAS GENES MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CRISPR & CAS GENES MARKET SIZE, BY DESIGN TOOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 10. CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CRISPR & CAS GENES MARKET SIZE, BY DNA-FREE CAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CRISPR & CAS GENES MARKET SIZE, BY VECTOR-BASED CAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CRISPR & CAS GENES MARKET SIZE, BY LIBRARIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 15. CRISPR & CAS GENES MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CRISPR & CAS GENES MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CRISPR & CAS GENES MARKET SIZE, BY DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. CRISPR & CAS GENES MARKET SIZE, BY GRNA DESIGN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CRISPR & CAS GENES MARKET SIZE, BY MICROBIAL GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CRISPR & CAS GENES MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 23. CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. CRISPR & CAS GENES MARKET SIZE, BY DISEASE MODEL STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. CRISPR & CAS GENES MARKET SIZE, BY EPIGENETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. CRISPR & CAS GENES MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. CRISPR & CAS GENES MARKET SIZE, BY GENOME ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CRISPR & CAS GENES MARKET SIZE, BY ACADEMICS & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 323. CRISPR & CAS GENES MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 324. CRISPR & CAS GENES MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 325. CRISPR & CAS GENES MARKET LICENSE & PRICING